News

A group of 20 patient and physician groups submitted comments today regarding the proposed rule on Durable Medical Equipment (DME) and its application to supplemental oxygen. Below is a statement from the seven organizations leading the coalition:

The Pulmonary Fibrosis Foundation (PFF) announced that it has achieved its enrollment goal for the initial phase of the PFF Patient Registry with participation of 2,002 patients. The Registry, launched in 2016, is a collection of comprehensive anonymized data from patients living with pulmonary fibrosis (PF), a group of fatal lung diseases which cause progressive scarring in the lungs.

For more than one million people living with serious lung conditions, such as pulmonary fibrosis (PF), a prescription for supplemental oxygen therapy can seem overwhelming. Questions like which oxygen delivery system to use, how to manage various flow settings, or how to ensure safety sometimes cause confusion and stress with the oxygen process.

The Pulmonary Fibrosis Foundation (PFF) has expanded its annual PFF Walk in Chicago to New York and Washington D.C. to raise awareness and funds in its quest to find a cure for pulmonary fibrosis (PF), a relentlessly progressive group of devastating lung disorders.

Patients and caregivers will join physicians, researchers and industry professionals at the JW Marriott San Antonio Hill Country for the Pulmonary Fibrosis Foundation’s (PFF) biennial PFF Summit, Nov. 7-9, 2019.